Literature DB >> 9499084

The gene product of human cytomegalovirus open reading frame UL56 binds the pac motif and has specific nuclease activity.

E Bogner1, K Radsak, M F Stinski.   

Abstract

Using the cis-acting human cytomegalovirus (HCMV) packaging elements (pac 1 and pac 2) as DNA probes, specific DNA-protein complexes were detected by electrophoretic mobility shift assay (EMSA) in both HCMV-infected cell nuclear extracts and recombinant baculovirus-infected cell extracts containing the HCMV p130 (pUL56) protein. DNA-binding proteins, which were common in uninfected and infected cell extracts, were also detected. Mutational analysis showed that only the AT-rich core sequences in these cis-acting motifs, 5'-TAAAAA-3' (pac 1) and 5'-TTTTAT-3' (pac 2), were required for specific DNA-protein complex formation. The specificity of the DNA-protein complexes was confirmed by EMSA competition. Furthermore, a specific endonuclease activity was found to be associated with lysates of baculovirus-infected cells expressing recombinant p130 (rp130). This nuclease activity was time dependent, related to the amount of rp130 in the assay, and ATP independent. Nuclease activity remained associated with rp130 after partial purification by sucrose gradient centrifugation, suggesting that this activity is a property of HCMV p130. We propose a possible involvement of p130 in HCMV DNA packaging.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9499084      PMCID: PMC109523          DOI: 10.1128/JVI.72.3.2259-2264.1998

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  20 in total

1.  Small-scale preparation of extracts from radiolabeled cells efficient in pre-mRNA splicing.

Authors:  K A Lee; M R Green
Journal:  Methods Enzymol       Date:  1990       Impact factor: 1.600

Review 2.  Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169.

Authors:  M S Chee; A T Bankier; S Beck; R Bohni; C M Brown; R Cerny; T Horsnell; C A Hutchison; T Kouzarides; J A Martignetti
Journal:  Curr Top Microbiol Immunol       Date:  1990       Impact factor: 4.291

Review 3.  Structure and assembly of the virion.

Authors:  W Gibson
Journal:  Intervirology       Date:  1996       Impact factor: 1.763

4.  Characterization of DNA sequence-common and sequence-specific proteins binding to cis-acting sites for cleavage of the terminal a sequence of the herpes simplex virus 1 genome.

Authors:  J Chou; B Roizman
Journal:  J Virol       Date:  1989-03       Impact factor: 5.103

5.  The alpha sequence of the cytomegalovirus genome functions as a cleavage/packaging signal for herpes simplex virus defective genomes.

Authors:  R R Spaete; E S Mocarski
Journal:  J Virol       Date:  1985-06       Impact factor: 5.103

6.  Transcription initiation sites and nucleotide sequence of a herpes simplex virus 1 gene conserved in the Epstein-Barr virus genome and reported to affect the transport of viral glycoproteins.

Authors:  P E Pellett; F J Jenkins; M Ackermann; M Sarmiento; B Roizman
Journal:  J Virol       Date:  1986-12       Impact factor: 5.103

7.  Functional domains within the a sequence involved in the cleavage-packaging of herpes simplex virus DNA.

Authors:  L P Deiss; J Chou; N Frenkel
Journal:  J Virol       Date:  1986-09       Impact factor: 5.103

8.  The AAV origin binding protein Rep68 is an ATP-dependent site-specific endonuclease with DNA helicase activity.

Authors:  D S Im; N Muzyczka
Journal:  Cell       Date:  1990-05-04       Impact factor: 41.582

9.  A host cell protein binds to a highly conserved sequence element (pac-2) within the cytomegalovirus a sequence.

Authors:  G W Kemble; E S Mocarski
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

10.  Isolation of antigen from Litomosoides carinii macrofilariae detecting serum antibodies due to Onchocerca volvulus.

Authors:  A Klenk; E Geyer; H Zahner; H J Trojan
Journal:  Z Parasitenkd       Date:  1983
View more
  57 in total

1.  Herpes simplex virus DNA packaging sequences adopt novel structures that are specifically recognized by a component of the cleavage and packaging machinery.

Authors:  K Adelman; B Salmon; J D Baines
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

2.  Phosphorylation of beta-D-ribosylbenzimidazoles is not required for activity against human cytomegalovirus.

Authors:  Paula M Krosky; Katherine Z Borysko; M Reza Nassiri; Rodrigo V Devivar; Roger G Ptak; Michelle G Davis; Karen K Biron; Leroy B Townsend; John C Drach
Journal:  Antimicrob Agents Chemother       Date:  2002-02       Impact factor: 5.191

3.  Effects of mutations within the herpes simplex virus type 1 DNA encapsidation signal on packaging efficiency.

Authors:  P D Hodge; N D Stow
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

4.  Point mutations in exon I of the herpes simplex virus putative terminase subunit, UL15, indicate that the most conserved residues are essential for cleavage and packaging.

Authors:  Angela J Przech; Dong Yu; Sandra K Weller
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

5.  Structure and inhibition of herpesvirus DNA packaging terminase nuclease domain.

Authors:  Marta Nadal; Philippe J Mas; Phillipe J Mas; Alexandre G Blanco; Carme Arnan; Maria Solà; Darren J Hart; Miquel Coll
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-30       Impact factor: 11.205

6.  Linker insertion mutations in the herpes simplex virus type 1 UL28 gene: effects on UL28 interaction with UL15 and UL33 and identification of a second-site mutation in the UL15 gene that suppresses a lethal UL28 mutation.

Authors:  Jennie G Jacobson; Kui Yang; Joel D Baines; Fred L Homa
Journal:  J Virol       Date:  2006-10-11       Impact factor: 5.103

7.  The UL6 gene product forms the portal for entry of DNA into the herpes simplex virus capsid.

Authors:  W W Newcomb; R M Juhas; D R Thomsen; F L Homa; A D Burch; S K Weller; J C Brown
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

8.  Impact of 2-bromo-5,6-dichloro-1-beta-D-ribofuranosyl benzimidazole riboside and inhibitors of DNA, RNA, and protein synthesis on human cytomegalovirus genome maturation.

Authors:  Michael A McVoy; Daniel E Nixon
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

9.  Epstein-Barr virus BALF3 has nuclease activity and mediates mature virion production during the lytic cycle.

Authors:  Shih-Hsin Chiu; Meng-Chuan Wu; Chung-Chun Wu; Yu-Ching Chen; Su-Fang Lin; John T-A Hsu; Chung-Shi Yang; Ching-Hwa Tsai; Kenzo Takada; Mei-Ru Chen; Jen-Yang Chen
Journal:  J Virol       Date:  2014-02-19       Impact factor: 5.103

10.  Inhibition of human cytomegalovirus replication by benzimidazole nucleosides involves three distinct mechanisms.

Authors:  David L Evers; Gloria Komazin; Roger G Ptak; Dongjin Shin; Brian T Emmer; Leroy B Townsend; John C Drach
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.